The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.83BCNY
554.15M · vs all stocks (USD)
Updated Nov 22, 2026
Revenue (TTM)
327.45MCNY
44.46M · vs all stocks (USD)
Updated Nov 22, 2026
Profit Margin
-106.69%
Updated Nov 22, 2026
Beta
0.3270x
vs all stocks
Updated Nov 22, 2026
52-Week Change
-67.17%
vs all stocks
Updated Nov 22, 2026
Market Capitalization
2.83BCNY
554.15M · vs all stocks (USD)
Updated Nov 22, 2026
Enterprise Value
2.85BCNY
556.98M · vs all stocks (USD)
Updated Nov 22, 2026
Forward P/E
15.00x
Updated Nov 22, 2026
Price to Sales (TTM)
8.63x
Updated Nov 22, 2026
Price to Book (MRQ)
3.18x
Updated Nov 22, 2026
Enterprise to Revenue
8.69x
Updated Nov 22, 2026
Enterprise to EBITDA
-8.72x
Updated Nov 22, 2026
Gross Margin
28.01%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 53.01%.Updated Nov 22, 2026
Profit Margin
-106.69%
Updated Nov 22, 2026
Operating Margin
-105.81%
Updated Nov 22, 2026
Return on Assets (TTM)
-11.85%
Updated Nov 22, 2026
Return on Equity (TTM)
-33.86%
Updated Nov 22, 2026
Revenue (TTM)
327.45MCNY
44.46M · vs all stocks (USD)
Updated Nov 22, 2026
Revenue per Share (TTM)
0.2260CNYUpdated Nov 22, 2026
Quarterly Revenue Growth
379.70%
Updated Nov 22, 2026
Gross Profit (TTM)
173.59MCNY
23.84M · vs all stocks (USD)
Updated Nov 22, 2026
EBITDA (TTM)
-326.43MCNY
-51.93M · vs all stocks (USD)
Updated Nov 22, 2026
Net Income (TTM)
-349.36MCNY
-52.93M · vs all stocks (USD)
Updated Nov 22, 2026
Quarterly Earnings Growth (YoY)
-15.12%
Updated Nov 22, 2026
Operating Cash Flow (TTM)
61.52MCNY
6.30M · vs all stocks (USD)
Updated Nov 22, 2026
Levered Free Cash Flow (TTM)
261.93MCNY
37.82M · vs all stocks (USD)
Updated Nov 22, 2026
5-Year Average Dividend Yield
0.08%
vs all stocks
Updated Nov 22, 2026
Payout Ratio
0.00%
Updated Nov 22, 2026
Minority Interest (Equity)
-11.56MCNYFY2025 · Dec 31, 2025
Revenue
305.86MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
123.38MCNYFY2025 · Dec 31, 2025
Gross Profit
182.48MCNYFY2025 · Dec 31, 2025
Operating Income
-199.63MCNY
-29.92M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-363.55MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-22.10MCNYFY2025 · Dec 31, 2025
Net Income
-341.45MCNYFY2025 · Dec 31, 2025
EBIT
-357.08MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-125.45MCNYFY2025 · Dec 31, 2025
Research & Development
136.92MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
100.60MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
3.40MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
306.56KCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
6.47MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.2331CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.2331CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
1.45BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
1.45BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-341.45MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
3.44MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-301.78MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-310.98MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
38.90MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-341.45MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
9.11MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
21.16MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
9.40MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-9.20MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-74.56MCNYFY2025 · Dec 31, 2025
Sale of Investments
91.67MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
7.91MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
179.37MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-242.10MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-5.29MCNYFY2025 · Dec 31, 2025
Other Financing Charges
847.36KCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-67.18MCNYFY2025 · Dec 31, 2025
Shares Outstanding
1.45BSharesUpdated Nov 22, 2026
Float Shares
1.14BSharesUpdated Nov 22, 2026
% Held by Insiders
19.10%
vs all stocks
Updated Nov 22, 2026
% Held by Institutions
0.00%
vs all stocks
Updated Nov 22, 2026
Total Cash (MRQ)
30.41MCNY
5.56M · vs all stocks (USD)
Updated Nov 22, 2026
Total Cash per Share (MRQ)
0.0210CNYUpdated Nov 22, 2026
Total Debt (MRQ)
64.31MCNY
10.45M · vs all stocks (USD)
Updated Nov 22, 2026
Total Debt to Equity (MRQ)
0.0737x
Updated Nov 22, 2026
Current Ratio (MRQ)
0.7820x
Updated Nov 22, 2026
Book Value per Share (MRQ)
0.6130CNYUpdated Nov 22, 2026
Total Assets
1.80BCNY
270.28M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
715.08MCNYFY2025 · Dec 31, 2025
Total Liabilities
754.41MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.09BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
8.67MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
745.74MCNYFY2025 · Dec 31, 2025
Cash
40.36MCNYFY2025 · Dec 31, 2025
Cash Equivalents
6.60MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
46.96MCNYFY2025 · Dec 31, 2025
Accounts Receivable
310.43MCNYFY2025 · Dec 31, 2025
Inventory
277.23MCNYFY2025 · Dec 31, 2025
Accounts Payable
139.14MCNYFY2025 · Dec 31, 2025
Short-term Debt
155.62MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
103.97MCNYFY2025 · Dec 31, 2025
Long-term Debt
2.72MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
1.45BCNYFY2025 · Dec 31, 2025
Retained Earnings
-745.33MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.05BCNY
157.20M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
1.95CNYUpdated Nov 22, 2026
52-Week High
8.28CNYUpdated Nov 22, 2026
52-Week Change
-67.17%
vs all stocks
Updated Nov 22, 2026
Beta
0.3270x
vs all stocks
Updated Nov 22, 2026
50-Day MA
2.61CNYUpdated Nov 22, 2026
200-Day MA
3.96CNYUpdated Nov 22, 2026
Avg 10-Day Volume
14.48MSharesUpdated Nov 22, 2026
Avg 30-Day Volume
15.71MSharesUpdated Nov 22, 2026
Diluted EPS (TTM)
-0.2300CNYUpdated Nov 22, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price is falling, swinging wider than usual, and sits well below its peak.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 1.86: grey zoneSignificant
Altman Z-Score: 1.86
Supply Chain
Downstream position: depends on 18 industries, supplies 6Notable
Outgoing: 6.00Incoming: 18.00
High connectivity hub: 24 industry connectionsNotable
Total Connections: 24.00
Scale
Levered free cash flow is $37.82M, above the global median of $18.58MNotable